Compounds > tributyrin
Page last updated: 2024-08-17

tributyrin and Experimental Hepatoma

tributyrin has been researched along with Experimental Hepatoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrade, FO; Farsky, SHP; Fernandes, LHG; Furtado, KS; Hebeda, CB; Heidor, R; Horst, MA; Miranda, MLP; Moreno, FS; Sandri, S; Yamamoto, RC1
Beland, FA; de Conti, A; Heidor, R; Koturbash, I; Kuroiwa-Trzmielina, J; Moreno, FS; Ong, TP; Pogribny, IP; Tryndyak, V1
de Conti, A; de Paiva, SA; Furtado, KS; Gioielli, LA; Heidor, R; Moreno, FS; Ortega, JF; Pogribny, IP; Purgatto, E; Ract, JN; Silva, RC; Tavares, PE1
de Conti, A; Horst, MA; Kuroiwa-Trzmielina, J; Moreno, FS; Ong, TP; Pereira, D; Purgatto, E; Scolastici, C1
Bassoli, BK; Camargo, AA; Cavalher, FP; Chagas, CE; de Conti, A; Horst, MA; Jordão, AA; Kuroiwa-Trzmielina, J; Moreno, FS; Ong, TP; Purgatto, E; Scolastici, C; Vannucchi, H1

Other Studies

5 other study(ies) available for tributyrin and Experimental Hepatoma

ArticleYear
Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis.
    Carcinogenesis, 2019, 08-22, Volume: 40, Issue:8

    Topics: Actins; Angiogenesis Inhibitors; Animals; Apoptosis; Butyric Acid; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Gene Expression Regulation, Neoplastic; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Polysaccharides; Prodrugs; Rats; Triglycerides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2019
The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway.
    Carcinogenesis, 2013, Volume: 34, Issue:8

    Topics: Acetylation; Animals; Apoptosis; Butyric Acid; Carcinogenesis; Hepatocytes; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Liver Neoplasms, Experimental; Lysine; Male; Precancerous Conditions; Prodrugs; Random Allocation; Rats; Rats, Wistar; Signal Transduction; Triglycerides; Tumor Suppressor Protein p53; Up-Regulation

2013
The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis.
    Molecular nutrition & food research, 2016, Volume: 60, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Butyric Acid; Gene Expression Regulation; Histones; Linseed Oil; Lipids; Liver Neoplasms, Experimental; Male; Oncogenes; Precancerous Conditions; Rats, Wistar; Triglycerides

2016
Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug.
    International journal of cancer, 2009, Jun-01, Volume: 124, Issue:11

    Topics: Acetylation; Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Liver; Liver Neoplasms, Experimental; Male; Prodrugs; Rats; Rats, Wistar; Triglycerides; Tumor Suppressor Protein p53

2009
Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis.
    The Journal of nutritional biochemistry, 2012, Volume: 23, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Chemoprevention; Hepatocytes; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Liver; Liver Neoplasms, Experimental; Male; Precancerous Conditions; Rats; Rats, Wistar; rho GTP-Binding Proteins; Triglycerides; Vitamin A

2012